1．The Achievements and Future Directions of MIHARI Project
10.3820/jjpe.20.3
- VernacularTitle:1．MIHARI Project で得られた成果と今後の展望
- Author:
Chieko ISHIGURO
;
Yoshinori TAKEUCHI
;
Kaori YAMADA
;
Maki KOMAMINE
;
Yoshiaki UYAMA
- Publication Type:Journal Article
- Keywords:
adverse effect;
drug safety;
electric health record;
pharmacoepidemiology;
post-marketing
- From:Japanese Journal of Pharmacoepidemiology
2015;20(1):3-13
- CountryJapan
- Language:Japanese
-
Abstract:
PMDA, the Japanese regulatory agency, has worked for reinforcing and enhancing its post-marketing safety measures as stated in the second mid-term (FY 2009-2013) plan. MIHARI Project-Medical Information for Risk Assessment Initiative was started in FY 2009 to develop a new safety assessment system for post-marketing drugs using Japanese electronic healthcare data in PMDA. In the second mid-term, we examined characteristics of some electronic healthcare data available in Japan including, claims data, hospital information system data and Diagnosis Procedure Combination (DPC) data in order to make efficient use of those databases for the purpose of drug safety assessment. In addition, some pilot pharmacoepidemiological studies for risk assessment and drug utilization were conducted by use of these electronic healthcare data. Based on the accumulated findings, knowledge, and experiences from the pilot studies, we established the framework by FY 2013 to implement pharmacoepidemiology-based safety assessment in PMDA. In the third mid-term (FY 2014-2018), one of the important mission is to apply this framework into the current risk management process of drug safety. For that purpose, cooperation with other divisions of PMDA such as Office of Safety and Office of New Drug is a key. Simultaneously, we will work to establish an access to another database and novel pharmacoepidemiological methods using electronic healthcare data. A large-scale electronic health record database (MID-NET) as well as national claims database are expected to be an important database in the future activities of MIHARI Project. Furthermore, in April 2015, PMDA established new office focusing on Medical Informatics and Epidemiology for further promotion of electronic healthcare data utilization in Japan. In this article, we describe history and past activities of MIHARI Project followed by future challenges.
